Tactile Systems Technology, Inc. Sales-type Lease, Selling Profit (Loss)
Tactile Systems Technology, Inc. (TCMD) reported Sales-type Lease, Selling Profit (Loss) of $6.49 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SalesTypeLeaseSellingProfitLoss · last filed 2026-08-10
- Tactile Systems Technology, Inc. sales-type lease, selling profit (loss) for the quarter ending 2026-06-30 was $6.49M, a 12.93% increase year-over-year.
- Tactile Systems Technology, Inc. sales-type lease, selling profit (loss) for the quarter ending 2026-03-31 was $5.91M, a 12.72% decline year-over-year.
- Tactile Systems Technology, Inc. sales-type lease, selling profit (loss) for the quarter ending 2025-12-31 was $7.72M, a 8.66% increase year-over-year.
- Tactile Systems Technology, Inc. sales-type lease, selling profit (loss) for the quarter ending 2025-09-30 was $6.01M, a 16.82% decline year-over-year.
- Tactile Systems Technology, Inc. sales-type lease, selling profit (loss) for fiscal 2025 was $26.24M, a 2.93% increase from fiscal 2024.
- Tactile Systems Technology, Inc. sales-type lease, selling profit (loss) for fiscal 2024 was $25.49M, a 14.04% increase from fiscal 2023.
- Tactile Systems Technology, Inc. sales-type lease, selling profit (loss) for fiscal 2023 was $22.35M, a 7.82% decline from fiscal 2022.
- Tactile Systems Technology, Inc. sales-type lease, selling profit (loss) for fiscal 2022 was $24.25M, a 18.17% increase from fiscal 2021.
| Period end | Sales-type Lease, Selling Profit (Loss) 3 month | Sales-type Lease, Selling Profit (Loss) 6 month | Sales-type Lease, Selling Profit (Loss) 9 month | Sales-type Lease, Selling Profit (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.49M 10-Q · filed 2026-08-10 | $12.39M 10-Q · filed 2026-08-10 | $20.11M derived: sum of 3 quarters · filed 2026-08-10 | $26.12M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $5.91M 10-Q · filed 2026-05-04 | $13.63M derived: sum of 2 quarters · filed 2026-05-04 | $19.63M derived: sum of 3 quarters · filed 2026-05-04 | $25.38M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $7.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $13.73M derived: sum of 2 quarters · filed 2026-02-17 | $19.47M derived: sum of 3 quarters · filed 2026-08-10 | $26.24M 10-K · filed 2026-02-17 |
| 2025-09-30 | $6.01M 10-Q · filed 2025-11-03 | $11.75M derived: sum of 2 quarters · filed 2026-08-10 | $18.52M 10-Q · filed 2025-11-03 | $25.62M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $5.75M 10-Q · filed 2026-08-10 | $12.51M 10-Q · filed 2026-08-10 | $19.62M derived: sum of 3 quarters · filed 2026-08-10 | $26.84M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $6.77M 10-Q · filed 2026-05-04 | $13.87M derived: sum of 2 quarters · filed 2026-05-04 | $21.09M derived: sum of 3 quarters · filed 2026-05-04 | $27.19M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $14.33M derived: sum of 2 quarters · filed 2026-02-17 | $20.43M derived: sum of 3 quarters · filed 2026-02-17 | $25.49M 10-K · filed 2026-02-17 |
| 2024-09-30 | $7.22M 10-Q · filed 2025-11-03 | $13.32M derived: sum of 2 quarters · filed 2025-11-03 | $18.39M 10-Q · filed 2025-11-03 | $24.55M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $6.10M 10-Q · filed 2025-08-04 | $11.16M 10-Q · filed 2025-08-04 | $17.33M derived: sum of 3 quarters · filed 2026-02-17 | $24.84M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $5.07M 10-Q · filed 2025-05-05 | $11.23M derived: sum of 2 quarters · filed 2026-02-17 | $18.74M derived: sum of 3 quarters · filed 2026-02-17 | $24.10M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $6.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $13.67M derived: sum of 2 quarters · filed 2026-02-17 | $19.03M derived: sum of 3 quarters · filed 2026-02-17 | $22.35M 10-K · filed 2026-02-17 |
| 2023-09-30 | $7.51M 10-Q · filed 2024-11-04 | $12.87M derived: sum of 2 quarters · filed 2024-11-04 | $16.19M 10-Q · filed 2024-11-04 | $23.18M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $5.36M 10-Q · filed 2024-08-05 | $8.68M 10-Q · filed 2024-08-05 | $15.67M derived: sum of 3 quarters · filed 2025-02-18 | $22.39M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $3.32M 10-Q · filed 2024-05-06 | $10.30M derived: sum of 2 quarters · filed 2025-02-18 | $17.03M derived: sum of 3 quarters · filed 2025-02-18 | $22.80M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $6.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $13.71M derived: sum of 2 quarters · filed 2025-02-18 | $19.48M derived: sum of 3 quarters · filed 2025-02-18 | $24.25M 10-K · filed 2025-02-18 |
| 2022-09-30 | $6.72M 10-Q · filed 2023-11-06 | $12.49M derived: sum of 2 quarters · filed 2023-11-06 | $17.27M 10-Q · filed 2023-11-06 | $22.17M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $5.77M 10-Q · filed 2023-08-07 | $10.54M 10-Q · filed 2023-08-07 | $15.45M derived: sum of 3 quarters · filed 2024-02-20 | $21.05M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $4.77M 10-Q · filed 2023-05-08 | $9.68M derived: sum of 2 quarters · filed 2024-02-20 | $15.28M derived: sum of 3 quarters · filed 2024-02-20 | $20.50M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $10.51M derived: sum of 2 quarters · filed 2024-02-20 | $15.72M derived: sum of 3 quarters · filed 2024-02-20 | $20.52M 10-K · filed 2024-02-20 |
| 2021-09-30 | $5.60M 10-Q · filed 2022-11-07 | $10.82M derived: sum of 2 quarters · filed 2022-11-07 | $15.61M 10-Q · filed 2022-11-07 | $20.12M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $5.21M 10-Q · filed 2022-08-01 | $10.01M 10-Q · filed 2022-08-01 | $14.52M derived: sum of 3 quarters · filed 2023-02-21 | $18.48M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $4.80M 10-Q · filed 2022-05-02 | $9.31M derived: sum of 2 quarters · filed 2023-02-21 | $13.26M derived: sum of 3 quarters · filed 2023-02-21 | $17.05M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $8.47M derived: sum of 2 quarters · filed 2023-02-21 | $12.25M derived: sum of 3 quarters · filed 2023-02-21 | $16.62M 10-K · filed 2023-02-21 |
| 2020-09-30 | $3.96M 10-Q · filed 2021-11-08 | $7.74M derived: sum of 2 quarters · filed 2021-11-08 | $12.11M 10-Q · filed 2021-11-08 | $16.44M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $3.78M 10-Q · filed 2021-08-02 | $8.15M 10-Q · filed 2021-08-02 | $12.48M derived: sum of 3 quarters · filed 2022-02-23 | $16.64M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $4.37M 10-Q · filed 2021-05-03 | $8.70M derived: sum of 2 quarters · filed 2022-02-23 | $12.86M derived: sum of 3 quarters · filed 2022-02-23 | $16.01M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $8.49M derived: sum of 2 quarters · filed 2022-02-23 | $11.64M derived: sum of 3 quarters · filed 2022-02-23 | $14.06M 10-K · filed 2022-02-23 |
| 2019-09-30 | $4.16M 10-Q · filed 2020-11-02 | $7.31M derived: sum of 2 quarters · filed 2020-11-02 | $9.73M 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $3.15M 10-Q · filed 2020-08-03 | $5.58M 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $2.42M 10-Q · filed 2020-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |